Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

Oleanolic acid from grapes may increase chemotherapy effectiveness

3.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

4.

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

5.

Waiting for a Sharp Increase in Prostate Cancer Cases.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot